National Cancer Institute - US

Contact Info:

Liz Conner

https://genomics.ccr.cancer.gov/

Grants and Identifiers:

RRID: RRID:SCR_024754

Instrumentation:

Services Provided:

Relevant Publications:

1.) Robey RW, Fitzsimmons CM, Guiblet WM, Frye WJ, Dalmasy JM, Wang L, Russell DA, Huff LM, Perciaccante AJ, Ali-Rahmani F, Lipsey CC, Wade HM, Mitchell AV, Maligireddy SS, Terrero D, Butcher D, Edmondson EF, Jenkins LM, Nikitina T, Zhurkin VB, Tiwari AK, Piscopio AD, Totah RA, Bates SE, Arda HE, Gottesman MM, Batista PJ (2024 Apr 2). The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors Molecular cancer therapeutics, 23(4), 464-477. . PMCID: 11223745.

Description:

Core provides access to genomic technologies and Next-Generation Sequencing. Provides DNA and RNA quality control services, user accessible instrumentation, training, consultation services, bioinformatics support, and secure data delivery management.